Articles with public access mandates - ilyas sahinLearn more
Not available anywhere: 1
Methylated ctDNA quantification: non-invasive approach to monitoring hepatocellular carcinoma burden
I Angeli-Pahim, A Chambers, S Duarte, D Soma, T Beduschi, I Sahin, ...
Journal of the American College of Surgeons, 10.1097, 2023
Mandates: US National Institutes of Health
Available somewhere: 18
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation
AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ...
Cell reports 12 (4), 622-635, 2015
Mandates: US National Institutes of Health
Role of endothelial progenitor cells in cancer progression
M Moschetta, Y Mishima, I Sahin, S Manier, S Glavey, A Vacca, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 26-39, 2014
Mandates: US National Institutes of Health
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma
SV Glavey, S Manier, A Natoni, A Sacco, M Moschetta, MR Reagan, ...
Blood, The Journal of the American Society of Hematology 124 (11), 1765-1776, 2014
Mandates: US National Institutes of Health, Health Research Board, Ireland
Drug delivery approaches for the treatment of cervical cancer
F Ordikhani, M Erdem Arslan, R Marcelo, I Sahin, P Grigsby, JK Schwarz, ...
Pharmaceutics 8 (3), 23, 2016
Mandates: US National Institutes of Health
Pyk2 promotes tumor progression in multiple myeloma
Y Zhang, M Moschetta, D Huynh, YT Tai, Y Zhang, W Zhang, Y Mishima, ...
Blood, The Journal of the American Society of Hematology 124 (17), 2675-2686, 2014
Mandates: US National Institutes of Health
Targeting vasculogenesis to prevent progression in multiple myeloma
M Moschetta, Y Mishima, Y Kawano, S Manier, B Paiva, L Palomera, ...
Leukemia 30 (5), 1103-1115, 2016
Mandates: US National Institutes of Health
CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma
AK Azab, I Sahin, F Azab, M Moschetta, Y Mishima, N Burwick, ...
Blood, The Journal of the American Society of Hematology 124 (12), 1905-1914, 2014
Mandates: US National Institutes of Health
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
AJ Olszewski, AD Chorzalska, M Petersen, TA Ollila, A Zayac, H Kurt, ...
Blood advances 5 (24), 5525-5535, 2021
Mandates: US National Institutes of Health
MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection
L Zhou, K Huntington, S Zhang, L Carlsen, EY So, C Parker, I Sahin, ...
Oncotarget 11 (46), 4201, 2020
Mandates: US National Institutes of Health
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy
AJ Olszewski, AD Chorzalska, AS Kim, PJ Quesenberry, ML Lopresti, ...
British journal of haematology 186 (3), e31, 2019
Mandates: US National Institutes of Health
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
I Sahin, Y Kawano, R Sklavenitis-Pistofidis, M Moschetta, Y Mishima, ...
Blood advances 3 (7), 995-1002, 2019
Mandates: US National Institutes of Health
Targeting survival and cell trafficking in multiple myeloma and W aldenstrom macroglobulinemia using panâclass I PI 3 K inhibitor, buparlisib
I Sahin, F Azab, Y Mishima, M Moschetta, B Tsang, SV Glavey, S Manier, ...
American journal of hematology 89 (11), 1030-1036, 2014
Mandates: US National Institutes of Health
Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination
I Sahin, M Moschetta, Y Mishima, SV Glavey, B Tsang, F Azab, S Manier, ...
Blood cancer journal 4 (4), e204-e204, 2014
Mandates: US National Institutes of Health
Strategies to sensitize cancer cells to immunotherapy
A George, I Sahin, BA Carneiro, DS Dizon, HP Safran, WS El-Deiry
Human Vaccines & Immunotherapeutics 17 (8), 2595-2601, 2021
Mandates: US National Institutes of Health
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance
K Alhallak, P de la Puente, A Jeske, J Sun, B Muz, MP Rettig, I Sahin, ...
Leukemia & Lymphoma 62 (10), 2457-2465, 2021
Mandates: US National Institutes of Health
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells
L Zhou, K Huntington, S Zhang, L Carlsen, EY So, C Parker, I Sahin, ...
Biorxiv, 2020
Mandates: US National Institutes of Health
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
K Alhallak, A Jeske, P de la Puente, J Sun, M Fiala, F Azab, B Muz, ...
Scientific reports 11 (1), 19343, 2021
Mandates: US National Institutes of Health
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma
R Singhal, SC Rogers, JH Lee, B Ramnaraign, I Sahin, JC Fabregas, ...
Future Oncology 19 (27), 1843-1853, 2023
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program